CLASS II Device recall · Reported 2 Jan 2013 · FDA Enforcement Report

Cobas AmpliPrep Instrument (Cap) with Amplilink (AL) recalled

Roche Molecular Systems is recalling Cobas AmpliPrep Instrument (Cap) with Amplilink (AL), distributed in California, Georgia, Minnesota, North Carolina. The recall was initiated on 11 Oct 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCAP 394436 to 394663
Quantity recalled7 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0614-2013
FDA event ID
63814
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Terminated
Recall initiated
11 Oct 2012
FDA classified
22 Dec 2012
Reported
2 Jan 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

11 Oct 2012Recall initiated by company
22 Dec 2012Classified by FDA+72 days
2 Jan 2013Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

COBAS AmpliPrep Instrument (CAP) with AMPLILINK (AL) Software v.3.3.5 Automated sample processing instrument used with CAP/CA and CAP/CTM. Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA Made in Switzerland

Where it was distributed

Distributed in the states of GA, CA, NC, and MN.

CaliforniaGeorgiaMinnesotaNorth Carolina

Questions about this recall

Is Cobas AmpliPrep Instrument (Cap) with Amplilink (AL) recalled?

Yes. Roche Molecular Systems recalled Cobas AmpliPrep Instrument (Cap) with Amplilink (AL) on 11 Oct 2012. The recall is Class II and its status is Terminated. Recall number Z-0614-2013.

Why was it recalled?

Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.

Which lots are affected?

CAP 394436 to 394663

Where was it sold?

Distributed in the states of GA, CA, NC, and MN.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other Medical Software recalls

All 903